Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Filings indexed 3,304 across all filing types
Latest filing 2022-02-07 Major Shareholding Noti…
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-07 English
SEC SCHEDULE 13G
Major Shareholding Notification
2022-02-04 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2022-02-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official notification released via RNS (Regulatory News Service) on February 1, 2022. The content explicitly states it is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1 and provides the total number of voting rights (1,549,420,147) as of January 31, 2022. This type of filing, which reports on the total issued share capital and voting rights, is a specific regulatory disclosure. While it relates to capital structure, it is not a general financing announcement (CAP) or a major shareholding notification (MRQ) about an investor crossing a threshold. It is a mandatory periodic disclosure regarding the total voting rights denominator. Since there is no specific category for 'Voting Rights Disclosure' other than DVA (Declaration of Voting Results), and this is a general disclosure about capital/voting rights rather than results of a vote, the most appropriate general regulatory category is RNS, as it is explicitly distributed via RNS and serves as a mandatory regulatory update that doesn't fit the more specific categories like DIV, SHA, or MRQ.
2022-02-01 English
IMFINZI IMPROVES SURVIVAL IN BILIARY TRACT CANCER
Foreign Filer Report
2022-01-19 English
IMFINZI COMBO SHOWS UNPRECEDENTED SURVIVAL IN HCC
Foreign Filer Report
2022-01-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.